Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Transcript
What special concerns do pregnant women have with hypertension? What signs should they look for if they have not experienced hypertension in the past?
One of the focuses of that particular paper in [the Journal of American College of Cardiology] JACC was hypertension across a woman's life cycle. The reason that this is important— in particular in pregnancy– [is that] there are several different issues that women need to think about. One is if a woman has pre-existing hypertension going into pregnancy, that's one issue and the hypertension has to be well controlled during the pregnancy.
But, an even bigger concern often is a woman who develops hypertension during pregnancy and/or preeclampsia. [This is] because what we know is that any level of hypertension during pregnancy, or the preeclamptic state, predicts for women a higher risk going forward of developing cardiovascular disease later on in her life.
In addition to the obstetric clinicians as well as internal medicine, family medicine, and even cardiologists who a woman might see, she really needs to be aware of her own blood pressure and to be asking those questions during the monitoring of her pregnancy as to "What is my blood pressure, do I have signs of preeclampsia, are there conditions that I need to worry about?"
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC
February 18th 2025Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).
Read More